Photo by nci from unsplash
Novel cardiac biomarkers serum (suppression of tumorigenicity [ST2]) and Galectin‐3 may be associated with an increased likelihood of important events after cardiac surgery. Our objective was to explore the association… Click to show full abstract
Novel cardiac biomarkers serum (suppression of tumorigenicity [ST2]) and Galectin‐3 may be associated with an increased likelihood of important events after cardiac surgery. Our objective was to explore the association between pre‐ and postoperative serum biomarker levels and 30‐day readmission or mortality for pediatric patients.
Keywords:
readmission mortality;
surgery;
day readmission;
mortality pediatric
Journal Title: Journal of Cardiac Surgery
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Cardiac Surgery
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!